She's in the testing room now. No time limit so hopefully, it doesn't take her longer than 1.5 hours. I'll need to eat & head to work in time to get there for my first session. 🤞🏻I can finally read or journal & fully fade into my music as I don't have to be aware of anything around me. It's not terrible, but there's a persistent unease in these public spaces that drain my 🥄
Plus my mama heart picks up on her #anxiety & testing is not fun for her #ADHD #autistic#neurodivergent @actuallyautistic
My first client is late today, so y'all get my braindumps this morning. I am 46. I guess that's in the window of possibly starting to experience #perimenopause. I haven't been able to determine if my temp regulation issues are because of #autism#anxiety or perimenopause. But they started getting really bad last yr. My husband had bought this same #Embr Wave Cooling Bracelet for his dad when he was going through chemo. It had helped him, so he bought one for me. 1/
Just was ‘diagnosed’ with anxiety today after talking to a psychiatrist for five minutes (I’m using quotes because it seems a bit too preliminary to me to diagnose whoever with whatever after about 5 minutes of general talk).
Came asking for #ADHD and #autism evaluation. Was totally ignored on that regard) Of course, didn’t have courage to ask again.
Was it so obvious? Was I just a walking stereotype: middle-aged woman from a war-thorn country living alone who voluntarily came to a psychiatrist(doesn’t matter what else she has, she can’t NOT be anxious)?
Or is it just a general experience of most of #AuDHD female-passing folks: to be seen as anxious, to have most of their symptoms attributed to #anxiety (not like I was asked about any symptoms, but maybe have demonstrated some?)?
Everytime I stand in front of the door and frantically search for the keys in my bag, all that #anxiety makes me panic, pushes me to the verge of tears - even though it is not such a big deal because I’m not in a hurry and if anything, the concierge has a spare pair.
So, naturally, my #autistic brain tries to compensate for a possible #ADHD fail - and every time I walk home, I feel almost unbeatable urge to get my keys out of my bag to my hand when I am still like 200 meters from home.
I suppose, it’s the same overcompensation mechanism that makes me come to airport at least two hours before the departure and to a train station at least an hour before, buy spares of essentials each time a bottle starts feeling not full, or always have a stocked pantry(though there may be multiple of ones and none of others as I always forget to check what I have before going to the store)
Is this exaggerated(to the point of creating problems) ‘better safe than sorry’ something #AuDHD people are more prone to? Do you guys also do that? @actuallyautistic
I am doing a survey about yoga and neurodivergent folk and your boosts would be appreciated.
If you are neurodivergent (self-realized or Dx'd, it's all good here), and fall under the vast ND umbrella, I'd love to hear from you. Quick 6-7 question survey and you can remain anon if you want.
Neat Nick’s Big Mess is an adorable picture book focusing on OCD and anxiety.
Chad Otis’ illustrations and story are charming and warm. I just fell in love with this friendly big dog. It is a wonderful story full of love and friendship that young readers, especially dog lovers, will adore !
There's shit you can't #rationalize yourself out of, unfortunately. Though the inclination to do so is always there. Makes for another energy leak on top of already having to deal with the matter at hand.
As a chronic people-pleaser, this is my advice for success.
Offer as little as possible. Be terse. Get rid of all those exclamation marks and tidbits about why you want to take a sick day. State your needs clearly and concisely without reason. Start saying “No, I’m unable.” more often. Say Thank You only when the other party deserves it.
Generation Anxiety A Millenial and Gen Z Guide to Staying Afloat in an Uncertain World by Lauren Cook
Millennials and Gen Z-ers are considered two of the most anxious generations in history, and with the many intense generation-specific stressors they've had to face in recent years—including climate change, political polarization, systemic racism, gun violence, and financial instability—it's easy to see why people are being diagnosed with anxiety at alarming rates @bookstodon #books #anxiety
For those with #MECFS, do you find yourself struggling with #Depression and/or #Anxiety since becoming ill, especially if it seems different from depression and/or anxiety that you experienced prior to becoming ill? If so, how are you managing your depression/anxiety? Have medications helped? Are you using non-medication approaches that work? @mecfs
A colleague of mine desperately needs someone to explain to him that the "assume you didn't get the job" mind trick is supposed to relieve anxiety, not be the depressive pole of it.
Email2Toot Robot. Please see entry below for author.
.
TITLE: COVID news
Thanks Dr. Lepkowsky
-------- Forwarded Message -------
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: No one planning holiday gatherings or travel wants to hear
this, but the rise of a new COVID-19 variant, JN.1, is concerning
experts (see "New COVID Variant JN.1 Could Disrupt Holiday Plans,"
"New SARS-CoV-2 variant JN.1 shows increased transmissibility and
immune resistance" and "Update on SARS-CoV-2 Variant JN.1 Being
Tracked by CDC" under Virology & Epidemiology).
In addition, an emerging variant of COVID-19 called BA.2.86 that
caused alarm earlier this summer has landed on the CDC's radar again
(see "New CDC Advisory Once Again Flags BA.2.86 COVID Variant" under
Virology & Epidemiology).
The U.S. government has expanded a program offering free COVID-19 and
flu tests and treatment (see "Federal Program Offers Free COVID, Flu
At-Home Tests, Treatments" under Policy).
Regional estimates of long COVID vary from less than 4% to more than
24% (see "Wide Regional Variation in Diagnosis of Long COVID" under
COVID Complications).
The loss of smell and taste associated with COVDI-19 infection usually
resolves, but can take up to three years to do so (see "Sensory
Comeback: New Findings Show the Path to Smell and Taste Recovery After
COVID" under COVID Complications).
COVID-19 combined with RSV and the flu to form a "Tripledemic" (see
"'Tripledemic': Your Questions Answered" under Media News).
COVID vaccination demonstrably reduces emergency department visits for
children with COVID-19 (see "Effectiveness of Monovalent and Bivalent
mRNA Vaccines in Preventing COVID-19–Associated Emergency Department
and Urgent Care Encounters Among Children Aged 6 Months–5 Years" under
Vaccines, Treatment & Testing).
Long COVID cases now account for 6% of all workers' compensation
claims, but few are recognized (see "6% of Workers' Comp Cases Are for
Long COVID, But Many Can't Collect" under Policy).
New evidence shows for the first time that the virus that causes COVID
directly infects atherosclerotic plaques in the coronary arteries,
producing a persistent inflammatory response (see "COVID Coronary
Plaque Infection Confirms CV Risk" under COVID Complications).
Paxlovid (Nirmatrelvir-ritonavir) doesn't reduce the incidence of most
post-COVID conditions (see "Nirmatrelvir-Ritonavir Ineffective at
Reducing Most Post-COVID Conditions" under Vaccines, Treatment &
Testing).
The risk for Guillain-Barré syndrome (GBS) is six times higher in
people with COVID-19 in the 6 weeks following infection, according to
a new study that also showed receipt of the Pfizer-BioNTech mRNA
vaccine reduced GSB risk by 59% (see "mRNA Vaccine Cuts COVID-Related
Guillain-Barré Risk" under Vaccines, Treatment & Testing).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing
COVID-19–Associated Emergency Department and Urgent Care Encounters
Among Children Aged 6 Months–5 Years: https://www.medscape.com/viewarticle/995604?src=FYE
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
Private, vetted email list for mental health professionals: <https://www.clinicians-exchange.org>
Open Mastodon instance for all mental health workers: <https://mastodon.clinicians-exchange.org>
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @[email protected]
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <https://www.nationalpsychologist.com>
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
<http://subscribe-article-digests.clinicians-exchange.org>
.
READ ONLINE: <http://read-the-rss-mega-archive.clinicians-exchange.org>
It's primitive... but it works... mostly...
I've been thinking about gamifying the process of making new friends in my city. Kind of like a #LARP but your character is just yourself, and you earn points for showing up to small group events. Extra points for helping organize gatherings and coming up with creative ideas for people to get to know each other better.
...I've been thinking about this for over a year, maybe someday I'll have enough energy to actually start it.
Finally got a work albatross off my back after months. It was causing me such anxiety it was hard for me to even spend time on it. What’s worse is that it was a change forced upon us without any guidance on low impact solutions or consultation. I really loathe them. Bad IT.
I’m just glad it’s finally done. Spending time with family for a few days. It’ll be a nice break. (Exhale)
Quincy Kadin’s picture book is a personal testimony towards healing. I love how she shares strategies to help other children to work with their anxiety, help them navigate their feelings and feel better. Adhemas Batista’s illustrations are adorable and perfectly transcribe the different feelings of Frankie.
You are NOT a burden. Just because your brain is telling you so doesn't make it true. Your brain is lying to you. Your existence is not burdensome... and you. are. deserving.
It's important to remember that your worth is not determined by how someone else perceives you aswell.
You are deserving of love and support. You matter.
Shopping clothes is a huge issue for me. What I sometimes describe as "clothing store phobia", can perhaps be broke down to:
(Fear of) sensory overload: harsh lighting, music, advertisements, amounts of clothes and information to process
Anxiety because of uncertainty (e.g. about the available products and their prices)
Social phobia: Sometimes there are a lot of people in shops. Will they judge me for being "weird" (queer & neurodiverse)? Will I be brave enough to ask the sellers if I have some question? What if someone interacts with me and my brain shuts down?
Agoraphobia
Perhaps lightly traumatic experiences from sensory overload from previous store visits
I previously wrote about this issue on Mastodon, and I included some of the advice I got from there: https://todon.eu/@maxi/110338158852163385 (Unfortunately, part 2 of that toot got auto-deleted, but it only was about how to find a personal style)
I also got a lot of good advice from hashtags and groups!
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: Hospitalizations from COVID-19 rose for an eighth straight
week to 18,871 people/week see "COVID Hospitalizations Rise for Eighth
Week in a Row" under Virology & Epidemiology).
Moderna says its upcoming COVID-19 vaccine should work against the
BA.2.86 variant that has caused worry about a possible surge in cases
(see "New Moderna Vaccine to Work Against Recent COVID Variant" under
Vaccomes, Treatment & Testing).
COVID vaccines will have a new formulation this year, according to a
decision announced today by the US Food and Drug Administration that
will focus efforts on circulating variants. The move pushes last
year's bivalent vaccines out of circulation because they will no
longer be authorized for use in the United States (see "New COVID
Vaccines Force Bivalents Out" under Policy).
The CDC is not specifically saying whether long COVID patients should
get the new COVID boosters, flu shots, or RSV vaccines, and the Food
and Drug Administration (FDA) referred similar questions to the CDC
(see "Should Long COVID Patients Get the Flu, RSV, and New Booster
Shots?" under Policy).
Research continues to show that early intervention with antibiotics
reduces the risk of fatality from COID-19 (see "Early Empiric
Antibiotic Use in Patients Hospitalized With COVID-19" under Vaccines,
Treatment & Testing).
In ICU-patients ≥70 years old, COVID-19 is associated with greater
mortality rates than bacterial or viral pneumonia (see "Increased
Mortality in ICU Patients ≥70 Years Old With COVID-19 Compared to
Patients With Other Pneumonias" under COVID Complications).
After the US Food and Drug Administration authorized new monovalent
COVID vaccines, the CDC recommended the new booster vaccinations for
everyone (see "Universal Monovalent COVID Vaccines Backed by CDC"
under Policy).
About 103 million Americans had COVID-19, and about a third of those
led to long COVID. New data indicate that some cases of long COVID-19
might be going unidentified because the patient's initial infection
wasn't detected (see "Some People With Long COVID Tested Negative for
COVID-19" under COVID Complications).
Although SARS-CoV-2 infection among young children typically results
in mild infection, it can result in serious illness, including
multisystem inflammatory syndrome in children, long-term sequalae, and
death. mRNA COVID-19 vaccination provides protection against
symptomatic SARS-CoV-2 infection for at least 4 months after
vaccination among children aged 3–5 years (see "Safety Monitoring of
mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5
Years" under Vaccines, Treatment & Testing).
A new meta-analysis has shown that SGLT2 inhibitors do not lead to
lower 28-day all-cause mortality compared with usual care or placebo
in patients hospitalized with COVID-19 (see "SGLT2-inhibitors: No
Benefit in Hospitalized COVID-19" under Vaccines, Treatment &
Testing).
The COVID-19 booster vaccine typically causes transient, clinically
insignificant elevations in glucose levels in people with type 1
diabetes (see "COVID Booster May Transiently Raise Glucose Levels in
T1D" under Vaccines, Treatment & Testing).
"Cost May Lead Many to Skip COVID Testing: Why That's a Problem" (see
under Media News).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog #stillnotover
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: The updated vaccine that better protects against currently
circulating strains of the virus that causes COVID-19 may be available
as soon as next week (see "New COVID Shots Could Be Available Next
Week" under Vaccines, Treatment & Testing).
The increase in cases of COVID-19 in the northern hemisphere is
worrying healthcare authorities around the world, who are aware that
these countries usually experience a peak in respiratory infections
during the winter months (see "WHO 'Concerned' About COVID Increase in
Northern Hemisphere" under Virology & Epidemiology).
COVID-19 hospitalizations have been on the rise for weeks as summer
nears its end. COVID-19 hospitalizations rose by 19% last week and
COVID deaths by 21%, according to figures from the CDC. More than half
the states, 26, had a "substantial increase" in hospital admissions
(see "COVID-19 Hospitalizations and Deaths on the Rise" and "5
Questions for COVID Experts: How Concerned Should We Be?" under
Virology & Epidemiology).
COVID metrics have risen steadily since June after reaching the lowest
point since the pandemic started. However, just 7% of U.S. adults are
"very worried" about getting COVID-19 (see "COVID Metrics Tick Up, but
Americans Aren't Worried: Poll" under Media News).
The CDC and the World Health Organization have dubbed the BA 2.86
variant of COVID-19 as a variant to watch (see "Q&A: What to Know
About the New BA 2.86 COVID Variant" under Virology & Epidemiology).
However, BA.2.86 does not have a heightened ability to evade the
protection of COVID vaccines or immunity from prior infection (see
"Highly Mutated COVID Strain Can't Evade Immunity as Feared" under
Virology & Epidemiology).
Close and prolonged contact with someone with COVID-19 can more than
quadruple the risk of getting the virus (see "This Is When You're Most
at Risk for 'Leaky' COVID Immunity" under Virology & Epidemiology).
It's estimated that 1 out of 8 people with COVID develop long COVID.
Of those persons, 44% also experience headaches. Research has found
that many of those headaches are migraines — and many patients who are
afflicted say they had never had a migraine before (see "Long COVID
and New Migraines: What's the Link?" under COVID Complications).
Severe COVID infections may lead to lasting damage to the immune
system (see "Severe COVID May Cause Long-Term Cellular Changes: Study"
under COVID Complications).
COVID-19 may negatively affect the wound healing process while
increasing the mortality rate amongst patients with multiple or severe
comorbidities undergoing limb salvage procedure (see "Retrospective
Review of Complications and Outcomes in COVID-19–Positive Patients
With Comorbidities Undergoing Limb Salvage Procedures in a Tertiary
Care Wound Center" under COVID Complications).
Among patients with ARF due to COVID-19 pneumonia who fail HFNC, delay
of intubation beyond 24 h is associated with increased mortality (see
"Delayed Intubation Associated With In-hospital Mortality in Patients
With COVID-19" under Vaccines, treatment & Testing).
Crippling symptoms, lost careers, and eroded incomes: This is the
harsh reality for doctors suffering with long COVID, according to the
first major survey of physicians with the condition (see "One in Five
Doctors With Long COVID Can No Longer Work: Survey" under COVID
Complications).
EU regulators have recommended authorizing an updated COVID-19 vaccine
from Pfizer and its German partner BioNTech which targets the dominant
XBB.1.5 variant of Omicron, putting it on track to become the third
adapted shot by the two companies to be approved in the bloc (see "EU
Regulators Back Pfizer's Updated Vaccine for Dominant Omicron
Subvariant" under Policy).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
Charles M. Lepkowsky, Ph.D.
Solvang, CA
clepkowsky(at)gmail.com
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Okay all -- It's early days for figuring out how to help people with
Long COVID.
That said, a bit of promising research is starting to surface.
I'm taking the unusual step of emailing EVERYONE because at this point
many of you with anxiety and depression symptoms may have some Long
COVID (brain fog, sleep issues, the depression or anxiety itself!).
A good write-up about what Long COVID is can be found here. Yes, you
can had a trivial case of COVID-19 and still get Long COVID symptoms for
days, weeks, months, or years. Some cases of it are somewhat "mild": https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
*The bottom-line of the video is right at the end. For long COVID:
-- Get outside one hour per day.
-- May cover up if sensitive to sun (near UV rays will get through
clothing anyway)
-- Best if in nature (surrounded by green)
-- Do not look directly at sun (duh)
-- May wear a hat (near UV rays will get through clothing anyway)
-- Sitting in a sunny window no longer good enough (most glass now has
to be certified to block the rays we want)
He also promises to talk about how intermittent fasting may help in a
future video.
*
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical
Care, and Sleep Medicine and an Associate Professor at the University of
California, Riverside School of Medicine. He is also an ER doctor.
Before the pandemic, MedCram mainly seemed to be training for doctors to
pass exams. Since the start of COVID, Dr. Seheult has done occasional
more accessible videos for the general public on COVID-related topics.
To actually understand why something this simple may help -- and listen
to some research, please watch:
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]